Fundz

Axo Sim, Inc. reported raising $1.97 Million in an initial SEC Form D filing, from an offering of $3.77 Million

PRIVATEJun 15, 2020$2M of $3.8M raised

Amount Raised

$1.97 Million

$1.97 Million sold, per SEC Form D (first sale Jun 15, 2020)

Round Type

Venture

MetairieBiotechnologyHealth CareArtificial IntelligenceMachine Learning

Quick answer

28bio raised $1.97 Million in a funding round, dated June 15, 2020. 28bio is based in Metairie, Louisiana, United States.

How much did 28bio raise?
28bio raised $1.97 Million in a funding round on June 15, 2020.
What does 28bio do?
28bio was formerly known as AxoSim, Inc. 28bio is a neurotechnology company engineering human brains at-scale exhibiting memory, learning, and cognitive functions.
Where is 28bio based and how big is it?
28bio is based in Metairie, Louisiana, United States. Fundz records about 15 employees.
Who are the decision-makers at 28bio?
Fundz holds 3 contacts at 28bio. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as 28bio that raised within 45 days of this round, from Fundz verified event records.

  • IMIDEX Inc. raised $1.3M (Seed) on July 7, 2020.
  • SRX Global Inc. raised $1.5M (Seed) on June 30, 2020.
  • CurvaFix raised $45M (Series B) on July 29, 2020.
  • MBX Biosciences, Inc. raised $34M (Series A) on July 27, 2020.
  • Enzyre raised an undisclosed amount (Funding Round) on July 27, 2020.
  • Lisata Therapeutics raised $2M (Seed) on July 27, 2020.

Who to call at 28bio, and when

A new round usually means 28bio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day 28bio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at 28bio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at 28bio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

28bio

Location

Metairie, Louisiana, United States

About

28bio was formerly known as AxoSim, Inc. 28bio is a neurotechnology company engineering human brains at-scale exhibiting memory, learning, and cognitive functions. Its Nexon™ platform integrates tissue engineering, neural interfacing, and AI to reverse today's neurological health crisis by improving the ability to predict which therapies will work in humans. 28bio is committed to advancing ethical standards in the development of brain organoid technology and engineered human cognition.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment 28bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Predictive Intelligence
Strategic

ML-powered predictions for 28bio's next move

See what Strategic adds

28bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.